Maternal choline supplementation programs greater activity of the phosphatidylethanolamine N-methyltransferase (PEMT) pathway in adult Ts65Dn trisomic mice.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4202107)

Published in FASEB J on June 24, 2014

Authors

Jian Yan1, Stephen D Ginsberg2, Brian Powers1, Melissa J Alldred3, Arthur Saltzman4, Barbara J Strupp1, Marie A Caudill5

Author Affiliations

1: Division of Nutritional Sciences, Cornell University, Ithaca, New York, USA;
2: Center for Dementia Research, Nathan Kline Institute, Orangeburg, New York, USA; and Department of Psychiatry and Department of Physiology and Neuroscience, New York University Langone Medical Center, New York, New York, USA.
3: Center for Dementia Research, Nathan Kline Institute, Orangeburg, New York, USA; and Department of Psychiatry and.
4: Center for Dementia Research, Nathan Kline Institute, Orangeburg, New York, USA; and.
5: Division of Nutritional Sciences, Cornell University, Ithaca, New York, USA; mac379@cornell.edu.

Articles cited by this

Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol (2010) 7.00

A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet (1995) 4.95

Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol (1985) 3.83

Food intake, water intake, and drinking spout side preference of 28 mouse strains. Behav Genet (2002) 3.26

Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol (2000) 2.78

A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci (2005) 2.36

Quantitation of choline and its metabolites in tissues and foods by liquid chromatography/electrospray ionization-isotope dilution mass spectrometry. Anal Chem (2002) 2.35

Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci U S A (1996) 2.32

Segmental trisomy as a mouse model for Down syndrome. Prog Clin Biol Res (1993) 2.29

Metabolic imprinting of choline by its availability during gestation: implications for memory and attentional processing across the lifespan. Neurosci Biobehav Rev (2003) 2.10

Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers. Am J Physiol (1992) 1.81

Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) (1984) 1.78

Pre- and postnatal choline supplementation produces long-term facilitation of spatial memory. Dev Psychobiol (1988) 1.72

A behavioral assessment of Ts65Dn mice: a putative Down syndrome model. Neurosci Lett (1995) 1.70

Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine methylation pathway. J Biol Chem (1999) 1.54

Choline supplementation during prenatal development reduces proactive interference in spatial memory. Brain Res Dev Brain Res (1999) 1.47

The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J Neurosci (2009) 1.46

Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of Down syndrome. Neurosci Lett (1998) 1.43

Organizational changes in cholinergic activity and enhanced visuospatial memory as a function of choline administered prenatally or postnatally or both. Behav Neurosci (1989) 1.38

Phosphatidylethanolamine-N-methyltransferase activity and dietary choline regulate liver-plasma lipid flux and essential fatty acid metabolism in mice. J Nutr (2003) 1.36

Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome. Exp Neurol (2000) 1.35

Prenatal choline supplementation mitigates the adverse effects of prenatal alcohol exposure on development in rats. Neurotoxicol Teratol (2009) 1.30

Developmental periods of choline sensitivity provide an ontogenetic mechanism for regulating memory capacity and age-related dementia. Front Integr Neurosci (2008) 1.26

Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis. Exp Neurol (1998) 1.24

Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome. Mamm Genome (2011) 1.19

Regional deafferentation down-regulates subtypes of glutamate transporter proteins. J Neurochem (1995) 1.19

Prenatal choline supplementation mitigates behavioral alterations associated with prenatal alcohol exposure in rats. Birth Defects Res A Clin Mol Teratol (2010) 1.17

The origin of numerical chromosome abnormalities. Adv Genet (1995) 1.16

Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice. Brain Res (2000) 1.11

Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J Alzheimers Dis (2012) 1.11

Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome. Behav Neurosci (2010) 1.09

The topography of plaques and tangles in Down's syndrome patients of different ages. Neuropathol Appl Neurobiol (1987) 1.09

Use of phosphatide precursors to promote synaptogenesis. Annu Rev Nutr (2009) 1.09

Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: a review of human studies. Prostaglandins Leukot Essent Fatty Acids (2007) 1.07

Protective effects of prenatal choline supplementation on seizure-induced memory impairment. J Neurosci (2000) 1.01

MTHFR C677T genotype influences the isotopic enrichment of one-carbon metabolites in folate-compromised men consuming d9-choline. Am J Clin Nutr (2010) 1.01

Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease. Behav Neurosci (2001) 1.01

Specificity and rate of human and mouse liver and plasma phosphatidylcholine synthesis analyzed in vivo. J Lipid Res (2010) 1.00

Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents. Metabolism (2008) 0.99

Folate intake, MTHFR genotype, and sex modulate choline metabolism in mice. J Nutr (2011) 0.98

PCR prescreen for genotyping the Ts65Dn mouse model of Down syndrome. Biotechniques (2010) 0.98

Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction. Neurobiol Dis (2011) 0.97

Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome. Neurobiol Dis (2013) 0.93

Choline redistribution during adaptation to choline deprivation. J Biol Chem (2007) 0.89

Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome. Hippocampus (2003) 0.88

Pregnancy alters choline dynamics: results of a randomized trial using stable isotope methodology in pregnant and nonpregnant women. Am J Clin Nutr (2013) 0.87

Administration of phosphatidylcholine increases brain acetylcholine concentration and improves memory in mice with dementia. J Nutr (1995) 0.87

Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease. Brain Pathol (2013) 0.84

Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice. J Comp Neurol (2014) 0.83

Water maze experience and prenatal choline supplementation differentially promote long-term hippocampal recovery from seizures in adulthood. Hippocampus (2010) 0.83

Neuroprotective actions of perinatal choline nutrition. Clin Chem Lab Med (2013) 0.80

Differential regulation of catechol-O-methyltransferase expression in a mouse model of aggression. Brain Struct Funct (2011) 0.80

Neuropsychiatric and behavioral aspects of trisomy 21. Curr Psychiatry Rep (2007) 0.79

Dementia in intellectual disability. Curr Opin Psychiatry (2014) 0.79